Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See [Seeking Alpha]
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director [Yahoo! Finance]
Here's What Makes Mizuho Bullish on Relmada Therapeutics Inc (RLMD) Stock [Yahoo! Finance]
Relmada Therapeutics (RLMD) is now covered by Piper Sandler. They set an "overweight" rating and a $12.00 price target on the stock.
Relmada Therapeutics (RLMD) had its price target raised by Mizuho from $10.00 to $19.00. They now have an "outperform" rating on the stock.